Since 2018, Dr. Susan Vadaparampil has served as Moffitt’s first Associate Center Director for Community Outreach, Engagement & Equity (COEE). In this role, she oversees the Office of COEE daily functions in support of Moffitt’s commitment to maximize the Center’s impact in the catchment area and beyond. The Office of COEE places health equity at the forefront of Moffitt’s research and outreach efforts by facilitating ongoing and bidirectional exchange of information and ideas between institutional leadership, faculty and the community we serve.
Dr. Vadaparampil is also a Senior Member in the Health Outcomes and Behavior Program in the Division of Population Sciences and a Professor in the Department of Oncologic Sciences at the University of South Florida College of Medicine. Her research uses a combination of behavioral science, epidemiology, health services, and clinical perspectives to improve dissemination and uptake of new cancer prevention and control innovations into clinical practice and the community. Her work is influenced by transdisciplinary collaboration, focused on health disparities, and contributes to both the scientific literature and clinical practice. Her current research focuses on genetic counseling and testing for inherited cancer susceptibility, breast and cervical cancer prevention/early detection, and reproductive health among adolescent and young adult cancer patients. She has been funded since 2006 through research grants from organizations such as the National Institutes of Health, the American Cancer Society and the Florida Biomedical Research Program. Dr. Vadaparampil has published over 270 scientific manuscripts. She also serves as the Co-Program Director for Moffitt’s Behavioral Oncology Post-Doctoral Training Program.
In 2019, she was awarded the American Cancer Society’s national St. George Award for over a decade of distinguished community service and contributions to ACS’s strategic goals in HPV vaccination and cancer health disparities. In 2020, she was appointed to the National Cancer Advisory Board based on her scientific accomplishments and leadership.